|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.030 CNY | +0.25% |
|
+2.69% | +1.13% |
| Market Cap | 4.67B 692M 599M 559M 514M 970M 65.79B 981M 6.56B 2.58B 32.92B 2.6B 2.54B 109B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.5B 667M 578M 538M 495M 935M 63.41B 945M 6.33B 2.48B 31.73B 2.5B 2.45B 105B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +0.25% | ||
| 1 week | +2.69% | ||
| Current month | +2.82% | ||
| 1 month | -3.25% | ||
| 3 months | -15.21% | ||
| 6 months | -21.58% | ||
| Current year | +1.13% |
| 1 week | 7.63 | 8.11 | |
| 1 month | 7.15 | 8.78 | |
| Current year | 7.08 | 11.38 | |
| 1 year | 7.08 | 11.98 | |
| 3 years | 3.58 | 11.98 | |
| 5 years | 3.58 | 11.98 | |
| 10 years | 3.58 | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 10/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 31/07/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 24/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 31/07/2019 |
Ying Yang
CHM | Chairman | 48 | 20/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 20/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.25% | +2.69% | -16.27% | +19.32% | 692M | ||
| +4.86% | -3.32% | +52.73% | +160.26% | 1,043B | ||
| +1.04% | -2.99% | +50.87% | +52.38% | 621B | ||
| +0.98% | -6.49% | +24.00% | +66.66% | 435B | ||
| +0.32% | +3.45% | +47.06% | +38.04% | 361B | ||
| +0.79% | -1.18% | +35.63% | +39.43% | 293B | ||
| +0.18% | -5.13% | +9.17% | +10.85% | 251B | ||
| +4.57% | +5.21% | +35.91% | +67.64% | 220B | ||
| +2.23% | -9.20% | +3.78% | -44.94% | 201B | ||
| -2.58% | -0.73% | +17.16% | +67.46% | 164B | ||
| Average | +0.86% | -2.88% | +26.00% | +47.71% | 358.98B | |
| Weighted average by Cap. | +0.99% | -3.79% | +38.50% | +76.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 146M 126M 118M 108M 204M 13.85B 207M 1.38B 542M 6.93B 547M 535M 22.96B | 1.21B 179M 155M 144M 133M 250M 16.98B 253M 1.69B 665M 8.49B 671M 656M 28.13B |
| Net income | 13.65M 2.02M 1.75M 1.63M 1.5M 2.83M 192M 2.87M 19.18M 7.53M 96.21M 7.59M 7.43M 319M | 92.73M 13.74M 11.9M 11.09M 10.2M 19.26M 1.31B 19.47M 130M 51.15M 654M 51.59M 50.45M 2.16B |
| Net Debt | 189M 28.01M 24.26M 22.61M 20.8M 39.26M 2.66B 39.7M 266M 104M 1.33B 105M 103M 4.41B | -169M -25M -21.66M -20.19M -18.57M -35.05M -2.38B -35.44M -237M -93.11M -1.19B -93.91M -91.84M -3.94B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | CN¥8.030 | +0.25% | 13,798,929 |
| 04/08/26 | CN¥8.010 | +2.04% | 13,878,553 |
| 03/08/26 | CN¥7.850 | +0.51% | 10,037,400 |
| 31/07/26 | CN¥7.810 | +2.63% | 14,775,420 |
| 30/07/26 | CN¥7.610 | -2.69% | 17,979,359 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
















